Phase III Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Immune Globulin for Multiple Sclerosis

NCT00004744 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
76
Enrollment
NIH
Sponsor class

Conditions

Interventions

Sponsor

National Institute of Neurological Disorders and Stroke (NINDS)

Collaborators